MetLife Investment Management’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $607K | Buy |
8,842
+497
| +6% | +$33.8K | ﹤0.01% | 1798 |
|
|
2026
Q1 | $626K | Sell |
8,345
-705
| -8% | -$57.8K | ﹤0.01% | 1639 |
|
|
2025
Q4 | $707K | Hold |
9,050
| – | – | ﹤0.01% | 1617 |
|
|
2025
Q3 | $769K | Hold |
9,050
| – | – | ﹤0.01% | 1600 |
|
|
2025
Q2 | $708K | Hold |
9,050
| – | – | ﹤0.01% | 1503 |
|
|
2025
Q1 | $655K | Sell |
9,050
-144
| -2% | -$12.1K | ﹤0.01% | 1578 |
|
|
2024
Q4 | $816K | Buy |
9,194
+504
| +6% | +$44.9K | ﹤0.01% | 1523 |
|
|
2024
Q3 | $735K | Hold |
8,690
| – | – | ﹤0.01% | 1570 |
|
|
2024
Q2 | $803K | Buy |
8,690
+977
| +13% | +$98.8K | ﹤0.01% | 1463 |
|
|
2024
Q1 | $871K | Hold |
7,713
| – | – | 0.01% | 1376 |
|
|
2023
Q4 | $718K | Hold |
7,713
| – | – | 0.01% | 1483 |
|
|
2023
Q3 | $708K | Buy |
7,713
+813
| +12% | +$87.3K | 0.01% | 1421 |
|
|
2023
Q2 | $838K | Buy |
6,900
+123
| +2% | +$13.3K | 0.01% | 1367 |
|
|
2023
Q1 | $664K | Hold |
6,777
| – | – | ﹤0.01% | 1468 |
|
|
2022
Q4 | $549K | Hold |
6,777
| – | – | ﹤0.01% | 1580 |
|
|
2022
Q3 | $515K | Hold |
6,777
| – | – | ﹤0.01% | 1615 |
|
|
2022
Q2 | $740K | Sell |
6,777
-325
| -5% | -$34.5K | 0.01% | 1389 |
|
|
2022
Q1 | $706K | Buy |
7,102
+2,693
| +61% | +$257K | ﹤0.01% | 1561 |
|
|
2021
Q4 | $421K | Hold |
4,409
| – | – | ﹤0.01% | 1595 |
|
|
2021
Q3 | $488K | Hold |
4,409
| – | – | ﹤0.01% | 1537 |
|
|
2021
Q2 | $511K | Sell |
4,409
-1,017
| -19% | -$117K | ﹤0.01% | 1554 |
|
|
2021
Q1 | $565K | Hold |
5,426
| – | – | 0.01% | 1454 |
|
|
2020
Q4 | $652K | Hold |
5,426
| – | – | 0.01% | 1342 |
|
|
2020
Q3 | $471K | Sell |
5,426
-961
| -15% | -$82.7K | 0.01% | 1393 |
|
|
2020
Q2 | $517K | Buy |
6,387
+1,084
| +20% | +$79.1K | 0.01% | 1360 |
|
|
2020
Q1 | $366K | Hold |
5,303
| – | – | 0.01% | 1378 |
|
|
2019
Q4 | $606K | Hold |
5,303
| – | – | 0.01% | 1352 |
|
|
2019
Q3 | $692K | Sell |
5,303
-708
| -12% | -$92.2K | 0.01% | 1248 |
|
|
2019
Q2 | $737K | Sell |
6,011
-12,022
| -67% | -$1.38M | 0.01% | 1266 |
|
|
2019
Q1 | $1.89M | Buy |
18,033
+12,022
| +200% | +$1.29M | 0.01% | 1292 |
|
|
2018
Q4 | $615K | Hold |
6,011
| – | – | 0.01% | 1239 |
|
|
2018
Q3 | $713K | Hold |
6,011
| – | – | 0.01% | 1312 |
|
|
2018
Q2 | $577K | Hold |
6,011
| – | – | 0.01% | 1326 |
|
|
2018
Q1 | $489K | Hold |
6,011
| – | – | 0.01% | 1379 |
|
|
2017
Q4 | $434K | Buy |
+6,011
| New | +$410K | ﹤0.01% | 1480 |
|
Other funds holding USPH
BG
CCM
SAM
MetLife Investment Management's USPH Position: Q2 2026 in Review
MetLife Investment Management increased its US Physical Therapy (USPH) stake by 6% in Q2 2026, buying an estimated $33.8K and bringing the position to 8,842 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #1798.
MetLife Investment Management first reported a position in USPH in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.89M in Q1 2019. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.
- MetLife Investment Management held 8,842 shares of US Physical Therapy worth $607K as of Q2 2026.
- MetLife Investment Management bought 497 US Physical Therapy shares in Q2 2026, an estimated $33.8K.
- US Physical Therapy made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1798 holding.
- MetLife Investment Management first reported a position in US Physical Therapy in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's US Physical Therapy position peaked at $1.89M in Q1 2019.
- 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.